What to expect of ExPEC: is the success of extraintestinal pathogenic E. coli li...
What to expect of ExPEC: is the success of extraintestinal pathogenic E. coli linked to specific genomic and cellular properties?
Extraintestinal pathogenic E. coli (ExPEC) are one of the greatest challenges for the healthcare system, with a frightening prognosis for the future. Despite being heavily studied in recent years, no unifying principle explaining...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PCIN-2016-096
IMPACTO QUE LA RESTRICCION ASOCIADA A HUESPED EN ESCHERICHIA...
147K€
Cerrado
PCIN-2015-094
PAPEL DE LA MICROBIOTA EN LA DEFENSA FRENTE A ENTEROBACTERIA...
150K€
Cerrado
PID2019-107479RB-I00
NUEVOS ASPECTOS DE LA VIRULENCIA EN LAS ENTEROBACTERIAS
121K€
Cerrado
BFU2011-23478
DETERMINACION DEL MECANISMO DEPENDIENTE DE RECA QUE GOBIERNA...
282K€
Cerrado
SAF2017-82261-P
BUSQUEDA DE NUEVOS FACTORES IMPLICADOS EN LA VIRULENCIA DEL...
109K€
Cerrado
PID2021-127010OB-I00
EVOLUCION A CORTO Y LARGO PLAZO DE PATOGENOS: FILOGENOMICA,...
169K€
Cerrado
Información proyecto EXCELLGEN
Duración del proyecto: 26 meses
Fecha Inicio: 2023-06-29
Fecha Fin: 2025-08-31
Descripción del proyecto
Extraintestinal pathogenic E. coli (ExPEC) are one of the greatest challenges for the healthcare system, with a frightening prognosis for the future. Despite being heavily studied in recent years, no unifying principle explaining their success has been identified. Only limited attention has been paid to the additional genomic properties of ExPEC strains that are not virulence factors or antimicrobial resistance genes. I aim to demonstrate that these additional genomic features lead to alterations in cellular features (related to physiology, growth ability and metabolism) that contribute to ExPEC (pathogenic) success. To do so, I will first setup a database of ExPEC specific regions and use this to perform an unbiased large-scale screen comparing them to publicly available E. coli genomes. This analysis will yield specific genomic regions that can be confidently assigned to ExPEC or ExPEC subgroups. To further demonstrate the biological significance of these regions, high-throughput single-cell phenomics will be employed to quantitatively examine specific strains of interest across different growth conditions and identify the genes or groups of genes present in the ExPEC specific regions associated with specific phenotypic alterations. Finally, the identified genomic regions will be further characterized using a deep mutational scanning approach to uncover the exact molecular mechanisms that underlie phenotypic alterations of pathogenic strains in comparison to their non-pathogenic counterparts. I expect this project to bring much-needed insights into ExPEC physiology, linking it with its specific genomic background. Such fundamental knowledge will contribute to managing ExPEC more effectively in the future.